RNA 干擾技術市場：按類型、治療方法、用途- 2023-2030 年全球預測

預計2023年全球RNA干擾技術市場規模為329.2億美元，年複合成長率為21.90%，預計2030年將達1354億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球RNA干擾技術市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對整體收入、客戶群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.RNA干擾技術的全球市場規模及預測為何？

2.在預測期內，COVID-19對全球RNA干擾技術市場的阻礙因素與影響為何？

3.預測期間全球RNA干擾技術市場有哪些產品/細分市場/應用/領域值得投資？

4.RNA干擾技術在全球市場的競爭策略為何？

5.RNA干擾技術全球市場的技術趨勢和法律規範是什麼？

6.全球RNA干擾技術市場主要廠商的市佔率為何？

7. RNA干擾技術進入全球市場適合採取哪些型態與策略措施？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 全球遺傳疾病和慢性病盛行率正在上升
    • RNAi技術在藥物研發和開發的應用不斷增加
    • 對分子診斷的需求不斷成長
  • 抑制因素
    • FDA 對 RNAi 治療的嚴格法規
  • 機會
    • 奈米技術和癌症領域的持續研究和開發
    • 正在開發的尖端 RNAi 療法
  • 任務
    • 實施RNA干擾療法的擔憂
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 RNA 干擾技術市場：依類型

• dsRNA
• miRNA
• siRNA

第7章 依治療領域分類的 RNA 干擾技術市場

• 自體免疫性肝炎
• 乙型和丙型肝炎
• 神經系統疾病
• 腫瘤學
• 呼吸系統疾病

第8章 RNA干擾技術市場：依用途

• 藥物研發發現與開發
• 療法

第9章 美洲RNA干擾技術市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第10章 亞太RNA干擾技術市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第11章歐洲、中東和非洲RNA干擾技術市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第12章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

• 討論指南
• 關於許可證和定價

The Global RNA Interference Technology Market is forecasted to grow significantly, with a projected USD 32.92 billion in 2023 at a CAGR of 21.90% and expected to reach a staggering USD 135.40 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global RNA Interference Technology Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global RNA Interference Technology Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across dsRNA, miRNA, and siRNA. The siRNA commanded largest market share of 37.14% in 2022, followed by miRNA.

Based on Therapeutics, market is studied across Autoimmune Hepatitis, Hepatitis B and C, Neurological Disorders, Oncology, and Respiratory Disorders. The Oncology commanded largest market share of 18.23% in 2022, followed by Hepatitis B and C.

Based on Application, market is studied across Drug Discovery and Development and Therapeutics. The Therapeutics commanded largest market share of 61.51% in 2022, followed by Drug Discovery and Development.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 39.14% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global RNA Interference Technology Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global RNA Interference Technology Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global RNA Interference Technology Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global RNA Interference Technology Market?

4. What is the competitive strategic window for opportunities in the Global RNA Interference Technology Market?

5. What are the technology trends and regulatory frameworks in the Global RNA Interference Technology Market?

6. What is the market share of the leading vendors in the Global RNA Interference Technology Market?

7. What modes and strategic moves are considered suitable for entering the Global RNA Interference Technology Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. RNA Interference Technology Market, by Type, 2022 vs 2030
• 4.3. RNA Interference Technology Market, by Therapeutics, 2022 vs 2030
• 4.4. RNA Interference Technology Market, by Application, 2022 vs 2030
• 4.5. RNA Interference Technology Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising Prevalence of Genetic and Chronic Disorders Globally
    • 5.1.1.2. Increasing Application of RNAi Technology in Drug Discovery & Development
    • 5.1.1.3. Growing Need for Molecular Diagnostics
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent FDA Regulations Regarding RNAi Therapies
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing Research and Development in the Field of Nanotechnology and Cancer
    • 5.1.3.2. State-of-the-art RNAi Therapies in Development
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns in Delivery of RNA-Interference Therapies
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. RNA Interference Technology Market, by Type

• 6.1. Introduction
• 6.2. dsRNA
• 6.3. miRNA
• 6.4. siRNA

7. RNA Interference Technology Market, by Therapeutics

• 7.1. Introduction
• 7.2. Autoimmune Hepatitis
• 7.3. Hepatitis B and C
• 7.4. Neurological Disorders
• 7.5. Oncology
• 7.6. Respiratory Disorders

8. RNA Interference Technology Market, by Application

• 8.1. Introduction
• 8.2. Drug Discovery and Development
• 8.3. Therapeutics

9. Americas RNA Interference Technology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific RNA Interference Technology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa RNA Interference Technology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. RNA INTERFERENCE TECHNOLOGY MARKET RESEARCH PROCESS
• FIGURE 2. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2022 VS 2030
• FIGURE 3. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2022 VS 2030 (%)
• FIGURE 6. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 7. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. RNA INTERFERENCE TECHNOLOGY MARKET DYNAMICS
• FIGURE 9. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. RNA INTERFERENCE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. RNA INTERFERENCE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. RNA INTERFERENCE TECHNOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DSRNA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY MIRNA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY SIRNA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 9. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY AUTOIMMUNE HEPATITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY HEPATITIS B AND C, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY NEUROLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 29. CANADA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 46. CHINA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. INDIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 49. INDIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 101. ITALY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. POLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. POLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 113. POLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. QATAR RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. QATAR RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 116. QATAR RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM RNA INTERFERENCE TECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. RNA INTERFERENCE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 145. RNA INTERFERENCE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 146. RNA INTERFERENCE TECHNOLOGY MARKET LICENSE & PRICING